Drug · DIN 02396750
INTELENCE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 8, 2023; first marketed June 14, 2013.
- Drug Identification Number (DIN)
- 02396750
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Etravirine J05AG04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ETRAVIRINE | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 20, 2012: NOC 13869Supplement to a New Drug Submission (SNDS) · New 25 mg tablet; New indication for pediatric patients 6 to <18 years of age
Other DINs named INTELENCE
- DIN 02306778 · Marketed
- DIN 02375931 · Marketed